Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
aphria.ca

See what CB Insights has to offer

Stage

Acq - P2P | Acquired

Total Raised

$6.24M

Valuation

$0000 

About Aphria

Pure Natures Wellness, dba Aphria, a privately-owned company incorporated under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing and supplying medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria. It is expected that, prior to the closing of the Business Combination, Aphria will have received its final license (the "License") from Health Canada designating Aphria as a "licensed producer" pursuant to the MMPR.

Aphria Headquarter Location

269 Erie St South

Leamington, Ontario, N8H 3C4,

Canada

844-427-4742

Latest Aphria News

Tilray Jumps on Cantor Fitzgerald Upgrade After Aphria Merger

Jun 3, 2021

Tilray Jumps on Cantor Fitzgerald Upgrade After Aphria Merger Cantor Fitzgerald upgraded cannabis provider Tilray to overweight and cut its price target on the stock to $22. Author: Jun 3, 2021 10:06 AM EDT Shares of Tilray  ( TLRY ) - Get Report  were higher Thursday after analysts at Cantor Fitzgerald upgraded the cannabis company to overweight from neutral while lowering its price target. The investment firm now has a $22 price target on the Nanaimo, British Columbia, company, down from $30.25. At last check Tilray shares were trading up 7.1% at $20.35. They're trading at less than a third of their 52-week high $67, set in early February. Tilray's nearly $4 billion merger with Aphria, which closed in May, combined Aphria's leading recreational position in Canada with Tilray's strength in international markets, according to Cantor analyst Pablo Zuanic. "We do not see another LP that can make these combined claims," said Zuanic, who called Tilray's stock a "bellwether" for the sector. He also sees tailwind for the sector as the pandemic eases and cannabis demand picks up. Cannabis stocks got a boost earlier this week after Amazon  ( AMZN ) - Get Report , one of the world's largest employers, voiced support for a federal bill to legalize marijuana. The Seattle tech and online-retail giant declared that it would no longer screen for marijuana for any position not regulated by the Department of Transportation. Dave Clark, Amazon's worldwide chief executive for consumer, said in a blog post that its public policy team would be actively supporting the Marijuana Opportunity Reinvestment and Expungement Act of 2021. The legislation would legalize marijuana at the federal level, expunge criminal records, and invest in affected communities, Clark said. "We hope that other employers will join us, and that policymakers will act swiftly to pass this law," he added.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Aphria

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Aphria in 1 CB Insights research brief, most recently on Jun 27, 2019.

Expert Collections containing Aphria

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Aphria is included in 2 Expert Collections, including Cannabis.

C

Cannabis

3,619 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Aphria Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Aphria Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.